Is there an ideal animal model for SARS?
- 1 July 2006
- journal article
- Published by Elsevier in Trends in Microbiology
- Vol. 14 (7) , 299-303
- https://doi.org/10.1016/j.tim.2006.05.007
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Recombinant Modified Vaccinia Virus Ankara Expressing the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus Induces Protective Neutralizing Antibodies Primarily Targeting the Receptor Binding RegionJournal of Virology, 2005
- Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in MiceThe Journal of Infectious Diseases, 2005
- Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian HamstersJournal of Virology, 2005
- Immunization with Modified Vaccinia Virus Ankara-Based Recombinant Vaccine against Severe Acute Respiratory Syndrome Is Associated with Enhanced Hepatitis in FerretsJournal of Virology, 2004
- Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeysVirology, 2004
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004
- Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of MiceJournal of Virology, 2004
- A DNA vaccine induces SARS coronavirus neutralization and protective immunity in miceNature, 2004
- Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern ChinaScience, 2003
- Newly discovered coronavirus as the primary cause of severe acute respiratory syndromePublished by Elsevier ,2003